Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Director departure
TELA Bio, Inc. (TELA) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/06/2023 SC 13G First Light Asset Management, LLC reports a 10.3% stake in TELA Bio, Inc.
09/28/2023 8-K Quarterly results
08/16/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Investor Contact"
08/10/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/09/2023 8-K Investor presentation, Quarterly results
Docs: "TELA Bio Reports Second Quarter 2023 Financial Results",
"Corporate Slide Deck"
05/11/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/11/2023 8-K Investor presentation, Quarterly results
Docs: "TELA Bio Reports First Quarter 2023 Financial Results",
"INVESTOR PRESENTATION May 2023"
04/21/2023 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
04/20/2023 8-K Quarterly results
04/20/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
04/19/2023 144 Form 144 - Report of proposed sale of securities:
04/18/2023 8-K Quarterly results
04/18/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
04/17/2023 ARS Form ARS - Annual Report to Security Holders:
04/17/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/17/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
03/23/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
03/23/2023 10-K Annual Report for the period ended December 31, 2022
03/23/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "TELA Bio Announces 510 Clearance for OviTex PRS Long-Term Resorbable for Plastic and Reconstructive Surgery"
03/21/2023 8-K Investor presentation, Quarterly results
Docs: "TELA Bio Reports Fourth Quarter and Full Year 2022 Financial Results",
"INVESTOR PRESENTATION March 2023"
02/14/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
01/10/2023 8-K Investor presentation
Docs: "INVESTOR PRESENTATION January 2023"
01/09/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "TELA Bio Announces U.S. Commercial Launch of NIVIS TM Fibrillar Collagen Pack, The Natural Restoration Solution to Support Healing of Surgical Wounds"
11/10/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/09/2022 8-K Quarterly results
10/26/2022 8-K Quarterly results
08/22/2022 SC 13D/A EW HEALTHCARE PARTNERS FUND 2, L.P. reports a 21.4% stake in TELA Bio, Inc.
08/19/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
08/17/2022 8-K Quarterly results
08/17/2022 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
08/15/2022 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
08/15/2022 8-K Quarterly results
08/11/2022 10-Q Quarterly Report for the period ended June 30, 2022
08/10/2022 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy